Metabolic Syndrome Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer

Overview of attention for article published in Frontiers in oncology, July 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 29,504 followers.

#BestStudyoftheDay: Metabolic syndrome predicts response to neoadjuvant chemotherapy in breast cancer - Front Oncol - #senology #breast #cancer #oncology https://t.co/7t01BjUul0 https://t.co/Dr9CFyQsLV

RT @Senology: #BestStudyoftheDay: Metabolic syndrome predicts response to neoadjuvant chemotherapy in breast cancer https://t.co/TcZfT3iYnL…

RT @Senology: #BestStudyoftheDay: Metabolic syndrome predicts response to neoadjuvant chemotherapy in breast cancer https://t.co/TcZfT3iYnL…

#BestStudyoftheDay: Metabolic syndrome predicts response to neoadjuvant chemotherapy in breast cancer https://t.co/TcZfT3iYnL - Front Oncol - #senology #breast #cancer #oncology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.